Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis
Year: 2000
Type: article
DOI: 10.1007/bf03339822
Authors: Alendronate Once-Weekly Study Group, T. Schnitzer, H. G. Bone, G. Crepaldi, S. Adami, M. McClung, D. Kiel, D. Felsenberg, R. R. Recker, R. P. Tonino, C. Roux, A. Pinchera, A. J. Foldes, S. L. Greenspan, M. A. Levine, R. Emkey, A. C. Santora, A. Kaur, D. E. Thompson, J. Yates, J. J. Orloff
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1966722256